FDA Schedules Pre-License Inspection of Remestemcel-L Manufacturing
Go back to FDA Schedules Pre-License Inspection of Remestemcel-L Manufacturing| Management Of Environmental Solutions & Technology (NASDAQ: MESO) | Delayed: 11.97 -1.31 (9.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.28 | 52 Week High | $10.89 | |||
| Open | $12.48 | 52 Week Low | $3.50 | |||
| Day High | $12.50 | P/E | N/A | |||
| Day Low | $11.93 | EPS | $0.00 | |||
| Volume | 297,906 | |||||
| MESABI TRUST (NYSE: MSB) | Delayed: 19.22 +1.34 (7.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.88 | 52 Week High | $11.74 | |||
| Open | $18.08 | 52 Week Low | $3.00 | |||
| Day High | $19.46 | P/E | 12.16 | |||
| Day Low | $18.08 | EPS | $1.58 | |||
| Volume | 30,600 | |||||



